Notice2024-00776
Methionine From Spain
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 17, 2024
Issuing agencies
International Trade Commission
Abstract
The U.S. International Trade Commission ("Commission") hereby gives notice of the procedures it intends to follow to comply with the court-ordered remand of its final determination in the antidumping duty investigation of methionine from Spain. For further information concerning the conduct of these remand proceedings and rules of general application, consult the Commission's Rules of Practice and Procedure.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 11 (Wednesday, January 17, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 11 (Wednesday, January 17, 2024)]
[Notices]
[Pages 2979-2980]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-00776]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 731-TA-1536 (Final) (Remand)]
Methionine From Spain
AGENCY: United States International Trade Commission.
ACTION: Notice of remand proceedings.
-----------------------------------------------------------------------
SUMMARY: The U.S. International Trade Commission (``Commission'')
hereby gives notice of the procedures it intends to follow to comply
with the court-ordered remand of its final determination in the
antidumping duty investigation of methionine from Spain. For further
information concerning the conduct of these remand proceedings and
rules of general application, consult the Commission's Rules of
Practice and Procedure.
[[Page 2980]]
DATES: January 11, 2024.
FOR FURTHER INFORMATION CONTACT: Calvin Chang ((202) 205-3358), Office
of Investigations, or Noah Meyer ((202) 708-1521), Office of General
Counsel, U.S. International Trade Commission, 500 E Street SW,
Washington, DC 20436. Hearing-impaired persons can obtain information
on this matter by contacting the Commission's TDD terminal on 202-205-
1810. Persons with mobility impairments who will need special
assistance in gaining access to the Commission should contact the
Office of the Secretary at 202-205-2000. General information concerning
the Commission may also be obtained by accessing its internet server
(<a href="https://www.usitc.gov">https://www.usitc.gov</a>). The public record for Investigation Nos. 731-
TA-1535-1536 (Final) may be viewed on the Commission's electronic
docket (EDIS) at <a href="https://edis.usitc.gov">https://edis.usitc.gov</a>.
SUPPLEMENTARY INFORMATION:
Background.--In June 2021, the Commission unanimously determined
that a domestic industry was materially injured by reason of imports of
methionine from France. Methionine from France, Inv. No. 731-TA-1534
(Final), USITC Pub. 5206 (June 2021). In September 2021, the Commission
determined that an industry in the United States was materially injured
by reason of imports of methionine from Japan and Spain that were sold
in the United States at less than fair value. Methionine from Japan and
Spain, Inv. Nos. 731-TA-1535-1536 (Final), USITC Pub. 5230 (Sept.
2021). Respondents, Adisseo Espana S.A. and Adisseo USA Inc., contested
the Commission's determination regarding Spain before the U.S. Court of
International Trade (``CIT''). The CIT remanded the Commission's
determination for the agency to reconsider ``the probative value and
factual accuracy of the volume of alleged lost sales used to support a
finding of adverse price effects in view of the competing methodology
proffered by Adisseo in its posthearing brief.'' Adisseo Espana S.A. et
al v. United States, Order accompanying Slip Op. 23-178 (Ct. Int'l
Trade, Dec. 18, 2023).
Participation in the remand proceedings.--Only those persons who
were interested parties that participated in the investigation of
Methionine from Spain and were also parties to the appeal may
participate in these remand proceedings. Such persons need not file any
additional appearances with the Commission to participate in the remand
proceedings, unless they are adding new individuals to the list of
persons entitled to receive business proprietary information (``BPI'')
under administrative protective order (``APO''). BPI referred to during
the remand proceedings will be governed, as appropriate, by the APO
issued in the investigations. The Secretary will maintain a service
list containing the names and addresses of all persons or their
representatives who are parties to the remand proceedings, and the
Secretary will maintain a separate list of those authorized to receive
BPI under the administrative protective order during the remand
proceedings.
Written submissions.--The Commission is not reopening the record
and will not accept the submission of new factual information for the
record. The Commission will permit the parties entitled to participate
in the remand proceedings to file comments concerning how the
Commission could best comply with the court's remand instructions.
The comments must be based solely on the information in the
Commission's record. The Commission will reject submissions containing
additional factual information or arguments pertaining to issues other
than those on which the court has remanded this matter. The deadline
for filing comments is Feb 16, 2024. Comments must be limited to no
more than ten (10) double-spaced and single-sided pages of textual
material, inclusive of attachments and exhibits.
Parties are advised to consult with the Commission's Rules of
Practice and Procedure, part 201, subparts A through E (19 CFR part
201), and part 207, subpart A (19 CFR part 207) for provisions of
general applicability concerning written submissions to the Commission.
All written submissions must conform to the provisions of section 201.8
of the Commission's rules; any submissions that contain BPI must also
conform with the requirements of sections 201.6, 207.3, and 207.7 of
the Commission's rules. Please note the Secretary's Office will accept
only electronic filings at this time. Filings must be made through the
Commission's Electronic Document Information System (EDIS, <a href="https://edis.usitc.gov">https://edis.usitc.gov</a>). No in-person paper-based filings or paper copies of
any electronic filings will be accepted until further notice. The
Commission's Handbook on E-Filing, available on the Commission's
website at <a href="http://edis.usitc.gov">http://edis.usitc.gov</a>, elaborates upon the Commission's
rules with respect to electronic filing.
Additional written submissions to the Commission, including
requests pursuant to section 201.12 of the Commission's rules, will not
be accepted unless good cause is shown for accepting such submissions
or unless the submission is pursuant to a specific request by a
Commissioner or Commission staff.
In accordance with sections 201.16(c) and 207.3 of the Commission's
rules, each document filed by a party to the investigation must be
served on all other parties to the investigation (as identified by
either the public or BPI service list), and a certificate of service
must be timely filed. The Secretary will not accept a document for
filing without a certificate of service.
By order of the Commission.
Issued: January 11, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024-00776 Filed 1-16-24; 8:45 am]
BILLING CODE 7020-02-P
</pre></body>
</html>Indexed from Federal Register on January 17, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.